Sotatercept in patients with pulmonary arterial hypertension at high risk for death (2025)
- Authors:
- Autor USP: SOUZA, ROGÉRIO DE - FM
- Unidade: FM
- DOI: 10.1056/NEJMoa2415160
- Subjects: HIPERTENSÃO PULMONAR; FATORES DE RISCO; PLACEBOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: New England Journal of Medicine
- ISSN: 0028-4793
- Volume/Número/Paginação/Ano: v. 392, n. 20, 2025
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
HUMBERT, Marc et al. Sotatercept in patients with pulmonary arterial hypertension at high risk for death. New England Journal of Medicine, v. 392, n. 20, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/88284. Acesso em: 02 abr. 2026. -
APA
Humbert, M., Mclaughlin, V. V., Badesch, D. B., Ghofrani, H. A., Gibbs, J. S. R., Gomberg-Maitland, M., et al. (2025). Sotatercept in patients with pulmonary arterial hypertension at high risk for death. New England Journal of Medicine, 392( 20). doi:10.1056/NEJMoa2415160 -
NLM
Humbert M, Mclaughlin VV, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Preston IR, Souza R de, Waxman AB, Moles VM. Sotatercept in patients with pulmonary arterial hypertension at high risk for death [Internet]. New England Journal of Medicine. 2025 ; 392( 20):[citado 2026 abr. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88284 -
Vancouver
Humbert M, Mclaughlin VV, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Preston IR, Souza R de, Waxman AB, Moles VM. Sotatercept in patients with pulmonary arterial hypertension at high risk for death [Internet]. New England Journal of Medicine. 2025 ; 392( 20):[citado 2026 abr. 02 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88284 - Incidência de hematomas subdurais espontâneos em casos de pacientes com hipertensão arterial pulmonar: Análise de um registro de cinco anos
- Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. [Carta]
- Pulmonary hypertension in sickle cell disease
- Challenging the concept of adding more drugs in pulmonary arterial hypertension [Editorial]
- Pulmonary arterialhHypertension-related morbidity is prognostic for mortality
- Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
- RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study
- 2016 – Um segundo passo [Editorial]
- Building the Future of Trial Design in PAH on Solid Ground
- Goal-oriented treatment of pulmonary arterial hypertension
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
